Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 4
1996 4
1997 7
1998 7
1999 4
2000 4
2001 3
2002 1
2004 1
2007 2
2008 2
2009 5
2010 4
2012 5
2013 2
2014 2
2015 4
2017 1
2018 1
2020 2
2021 2
2022 1
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for keilholz l
Search for Keilholtz L instead (1 results)
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
Stahler A, Hoppe B, Na IK, Keilholz L, Müller L, Karthaus M, Fruehauf S, Graeven U, Fischer von Weikersthal L, Goekkurt E, Kasper S, Kind AJ, Kurreck A, Alig AHS, Held S, Reinacher-Schick A, Heinemann V, Horst D, Jarosch A, Stintzing S, Trarbach T, Modest DP. Stahler A, et al. Among authors: keilholz l. J Clin Oncol. 2023 Jun 1;41(16):2975-2987. doi: 10.1200/JCO.22.02582. Epub 2023 Apr 5. J Clin Oncol. 2023. PMID: 37018649 Clinical Trial.
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation.
Obermayer B, Keilholz L, Conrad T, Frentsch M, Blau IW, Vuong L, Lesch S, Movasshagi K, Tietze-Stolley C, Loyal L, Henze L, Penack O, Stervbo U, Babel N, Haas S, Beule D, Bullinger L, Wittenbecher F, Na IK. Obermayer B, et al. Among authors: keilholz l. Front Immunol. 2023 Feb 10;14:1114368. doi: 10.3389/fimmu.2023.1114368. eCollection 2023. Front Immunol. 2023. PMID: 36860867 Free PMC article.
Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.
Rödel F, Fournier C, Wiedemann J, Merz F, Gaipl US, Frey B, Keilholz L, Seegenschmiedt MH, Rödel C, Hehlgans S. Rödel F, et al. Among authors: keilholz l. Front Immunol. 2017 May 3;8:519. doi: 10.3389/fimmu.2017.00519. eCollection 2017. Front Immunol. 2017. PMID: 28515727 Free PMC article. Review.
DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders.
Ott OJ, Niewald M, Weitmann HD, Jacob I, Adamietz IA, Schaefer U, Keilholz L, Heyd R, Muecke R; German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). Ott OJ, et al. Among authors: keilholz l. Strahlenther Onkol. 2015 Jan;191(1):1-6. doi: 10.1007/s00066-014-0757-3. Epub 2014 Sep 20. Strahlenther Onkol. 2015. PMID: 25238992 Review.
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial.
Fietkau R, Grützmann R, Wittel UA, Croner RS, Jacobasch L, Neumann UP, Reinacher-Schick A, Imhoff D, Boeck S, Keilholz L, Oettle H, Hohenberger WM, Golcher H, Bechstein WO, Uhl W, Pirkl A, Adler W, Semrau S, Rutzner S, Ghadimi M, Lubgan D. Fietkau R, et al. Among authors: keilholz l. Strahlenther Onkol. 2021 Jan;197(1):8-18. doi: 10.1007/s00066-020-01680-2. Epub 2020 Sep 10. Strahlenther Onkol. 2021. PMID: 32914237 Free PMC article. Clinical Trial.
[Radiotherapy for shoulder impingement].
Adamietz B, Sauer R, Keilholz L. Adamietz B, et al. Among authors: keilholz l. Strahlenther Onkol. 2008 May;184(5):245-50. doi: 10.1007/s00066-008-1789-3. Strahlenther Onkol. 2008. PMID: 18427754 German.
68 results